Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/2d3617b9-0353-4b11-8df2-ec4937d74302/

GMRS

GMR Solutions Inc.
Chart
12.97 USD
Latest Week 2026-07-24
HealthcareMedical Care FacilitiesSMALL
Snapshot 2026-07-26 · 0.6w · Fresh
0.9
OS Score
95.0%
Value
78.0%
Quality
35.0%
Momentum
#50.00000000
TV Rank
5/9
F-Score
0.861
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
7 of 23 passing
★
OS Composite
OS 0.900
↗
Trending Value
#50
◆
Quality × Value
QV 0.861
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
VC2 9
📐
EBITDA/EV
18.9%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 95%
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 1.00
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
95.0%ile
P/E
3.4×
P/S
0.1×
P/B
3.3×
E/P
0.1310
FCF Yield
0.159
EBITDA/EV
0.189
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
5.00000000
/100 — 1=cheapest
VC2 (Trending Value)
9.00000000
/100
VC3 (Buyback)
10.00000000
/100
P/E of 3.4x places this firmly in deep value territory. FCF yield of 15.9% is strong — the business generates significant free cash relative to price. VC2 score of 9.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
78.0%ile
ROE
0.970
ROA
0.028
Net Margin
0.036
Op Margin
0.129
GPA
0.304
D/E
33.52
Current
1.87
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.040
Earn Growth
1.446
Accruals
-0.059
lower=better
5yr Consist
No
ROE of 97% is exceptional. Highly leveraged with D/E of 33.52 — returns are being amplified by debt.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
35.0%ile
Vol 252d
84.0%
Vol 60d
84.0%
↓ Contracting
Max DD 12M
-18.5%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.9
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
98.0%
Sector Quality %ile
83.8%
P/E z-score
-0.42
P/B z-score
-0.15
Sector Avg OS
64.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 90.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 99.0% 92.0% 93.0% 92.0%
FBIO Fortress Biotech Inc 99.0% 98.0% 84.0% 87.0%
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 97.0%
NUTX Nutex Health Inc 99.0% 93.0% 98.0% 87.0%
CGEN Compugen 98.0% 90.0% 96.0% 83.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 86.0%
INVA Innoviva Inc 97.0% 94.0% 94.0% 67.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (95th) and quality (78th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Leveraged Returns
Strong ROE (97%) boosted by high leverage (D/E 33.5). Returns look good but come with balance sheet risk.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
79.4% avg (7 factors)
Quality
C
49.1% avg (8 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.900—8—
Value %ile0.950—8—
Quality %ile0.780—8—
Momentum %ile0.350—0—
F-Score5.000—0—
Confidence0.784—8—
Volatility0.840—2—
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
3.40
Earnings Yield (E/P)
0.1310
Price / Sales
0.12
Price / Book
3.29
Price / Cash Flow
1.09
FCF Yield
15.9%
EBITDA / EV
18.9%
Sales Yield (1/P·S)
1.0168
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
97.0%
Return on Assets
2.8%
Net Margin
3.6%
Operating Margin
12.9%
Gross Profit / Assets
Novy-Marx GPA
30.4%
Debt / Equity
33.52
Current Ratio
1.87
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.059
External Financing
Net issuance — lower=better
0.000
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-4.0%
Earnings Growth (YoY)
144.6%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
5
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
9
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
10
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
50
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity